🔗 Share this article

Former Prime Minister Rishi Sunak has reinforced his campaign for a specialized examination protocol for prostate gland cancer.

In a recently conducted interview, he declared being "persuaded of the urgency" of establishing such a system that would be cost-effective, achievable and "save numerous lives".

His remarks come as the UK National Screening Committee reevaluates its determination from half a decade past not to recommend standard examination.

News sources indicate the committee may continue with its present viewpoint.

Olympic Champion Contributes Support to Movement

Olympic cycling champion Sir Chris Hoy, who has advanced prostate gland cancer, wants men under 50 to be tested.

He suggests reducing the eligibility age for accessing a PSA blood screening.

Currently, it is not routinely offered to healthy individuals who are under 50.

The PSA test remains controversial nevertheless. Levels can elevate for causes apart from cancer, such as infections, causing incorrect results.

Skeptics maintain this can result in unwarranted procedures and adverse effects.

Focused Testing Proposal

The recommended screening programme would focus on men aged 45–69 with a family history of prostate cancer and men of African descent, who experience double the risk.

This demographic encompasses around 1.3 million individuals in the Britain.

Research projections propose the system would necessitate £25m per year - or about eighteen pounds per participant - comparable to colorectal and mammary cancer screening.

The estimate envisions one-fifth of suitable candidates would be notified yearly, with a 72% participation level.

Medical testing (imaging and tissue samples) would need to increase by almost a quarter, with only a reasonable increase in healthcare personnel, according to the report.

Medical Community Response

Some healthcare professionals remain uncertain about the value of examination.

They assert there is still a risk that individuals will be medically managed for the condition when it is not strictly necessary and will then have to live with complications such as bladder issues and impotence.

One leading urology specialist remarked that "The problem is we can often detect abnormalities that might not necessitate to be managed and we potentially create harm...and my concern at the moment is that risk to reward balance needs adjustment."

Individual Experiences

Individual experiences are also shaping the discussion.

A particular case features a man in his mid-sixties who, after asking for a prostate screening, was identified with the cancer at the time of fifty-nine and was told it had metastasized to his hip region.

He has since received chemo treatment, radiotherapy and endocrine treatment but cannot be cured.

The man supports screening for those who are at higher risk.

"That is essential to me because of my children – they are 38 and 40 – I want them screened as promptly. If I had been screened at fifty I am certain I would not be in the position I am today," he said.

Future Actions

The Screening Advisory Body will have to weigh up the evidence and arguments.

While the latest analysis suggests the consequences for workforce and capacity of a examination system would be feasible, some critics have argued that it would divert imaging resources from patients being treated for different health issues.

The continuing discussion highlights the multifaceted trade-off between prompt identification and potential overtreatment in prostate gland cancer management.